Retroviruses have come to serve as important model systems for regulation of genes at the post-transcriptional level. Complex retroviruses utilize trans acting viral proteins which act on specific cis-acting elements in the viral genome to achieve expression of intron-containing RNAs. In contrast, simpler retroviruses such as Mason-Pfizer Monkey Virus (MPMV) utilize cis-acting elements (CTEs) that interact directly with cellular proteins. Recent experiments in our laboratory indicate that the cellular protein Sam68 has the capacity to dramatically enhance the function of the MPMV CTE. Sam68 is an RNA-binding protein that is a major target for tyrosine phosphorylation by Src and other kinases in mitosis. Sam68 is also a substrate for Sik/Brk, a non-myristoylated member of the Src family that shows a mainly nuclear localization. Our experiments have shown that expression of constitutively active Sik/Brk inhibits SAM68 enhancement of CTE function in a dose dependent manner. We have also demonstrated that a Sam68-related protein (SLM-2/T-STAR) is able to enhance CTE function. Although the exact functions of Sam68 remain unknown, this protein appears to provide an important link between signal transduction and post-transcriptional gene regulation in mammalian cells. The fact that Sam68 regulates CTE function and viral gene expression provides us with a functional assay system through which this important link can be further analyzed. The major goals of this proposal are to further analyze the mechanism by which Sam68 promotes CTE function and to utilize this system to gain further insight into the role that Sam68 plays in cellular metabolism, The specific aims are:
Aim1 : To determine the mechanism by which SAM68 functions to enhance cytoplasmic utilization of CTE containing RNA.
Aim 2 : To analyze how phosphorylation and selected mutations affect the ability of Sam68 and SLM-2/T-STAR to enhance CTE function and to map specific phosphorylation sites in Sam68.
Aim 3 : To analyze whether Sam68 works directly by binding to CTE containing RNA or indirectly through interactions with other host-cells proteins.
Aim 4 : To identify and characterize in vivo cellular mRNA targets of Sam68.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA097095-01A2
Application #
6720849
Study Section
Experimental Virology Study Section (EVR)
Program Officer
Cole, John S
Project Start
2003-09-30
Project End
2008-08-31
Budget Start
2003-09-30
Budget End
2004-08-31
Support Year
1
Fiscal Year
2003
Total Cost
$302,171
Indirect Cost
Name
University of Virginia
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Rekosh, David; Hammarskjold, Marie-Louise (2018) Intron retention in viruses and cellular genes: Detention, border controls and passports. Wiley Interdiscip Rev RNA 9:e1470
Coyle, John H; Bor, Yeou-Cherng; Rekosh, David et al. (2011) The Tpr protein regulates export of mRNAs with retained introns that traffic through the Nxf1 pathway. RNA 17:1344-56
Shuck-Lee, Deidra; Chang, Hua; Sloan, Emily A et al. (2011) Single-nucleotide changes in the HIV Rev-response element mediate resistance to compounds that inhibit Rev function. J Virol 85:3940-9
Moore, Michael D; Nikolaitchik, Olga A; Chen, Jianbo et al. (2009) Probing the HIV-1 genomic RNA trafficking pathway and dimerization by genetic recombination and single virion analyses. PLoS Pathog 5:e1000627
Ward, Alex M; Rekosh, David; Hammarskjold, Marie-Louise (2009) Trafficking through the Rev/RRE pathway is essential for efficient inhibition of human immunodeficiency virus type 1 by an antisense RNA derived from the envelope gene. J Virol 83:940-52
Shuck-Lee, Deidra; Chen, Fei Fei; Willard, Ryan et al. (2008) Heterocyclic compounds that inhibit Rev-RRE function and human immunodeficiency virus type 1 replication. Antimicrob Agents Chemother 52:3169-79
Forrest, Scott T; Barringhaus, Kurt G; Perlegas, Demetra et al. (2004) Intron retention generates a novel Id3 isoform that inhibits vascular lesion formation. J Biol Chem 279:32897-903